BACKGROUND: Elevated plasma homocysteine and amyloid beta (Abeta) have been associated with Alzheimer's disease (AD). We investigated the cross-sectional association between these biomarkers. METHODS: We used linear regression to relate plasma homocysteine and Abeta adjusting for age, gender, creatinine, APOE-epsilon4, and ethnic group in 327 persons aged 78 +/- 6.6 years. RESULTS: Plasma homocysteine correlated with age, serum creatinine, plasma Abeta40 and Abeta42, and was inversely correlated with serum vitamin B12, and folate. Abeta42, but not Abeta40, was related to later development of dementia. Homocysteine was related to higher Abeta40 levels (coefficient = 2.0; P < 0.0001) and this association was attenuated after adjustment for creatinine (coefficient = 1.0; P < 0.0001). The crude association between homocysteine and Abeta42 was weaker (coefficient = 0.5; P = 0.01) and became non-significant after adjustment for creatinine (coefficient = 0.4; P = 0.06). These associations were unrelated to ethnicity, the presence of APOE-epsilon4 or dementia. Analyses by quartiles of homocysteine showed that these association were driven primarily by the fourth quartile. CONCLUSIONS: Plasma homocysteine is directly related to Abeta40. The association with Abeta42 is not significant. These results seem to indicate that homocysteine is related to aging but not specifically to AD.
BACKGROUND: Elevated plasma homocysteine and amyloid beta (Abeta) have been associated with Alzheimer's disease (AD). We investigated the cross-sectional association between these biomarkers. METHODS: We used linear regression to relate plasma homocysteine and Abeta adjusting for age, gender, creatinine, APOE-epsilon4, and ethnic group in 327 persons aged 78 +/- 6.6 years. RESULTS: Plasma homocysteine correlated with age, serum creatinine, plasma Abeta40 and Abeta42, and was inversely correlated with serum vitamin B12, and folate. Abeta42, but not Abeta40, was related to later development of dementia. Homocysteine was related to higher Abeta40 levels (coefficient = 2.0; P < 0.0001) and this association was attenuated after adjustment for creatinine (coefficient = 1.0; P < 0.0001). The crude association between homocysteine and Abeta42 was weaker (coefficient = 0.5; P = 0.01) and became non-significant after adjustment for creatinine (coefficient = 0.4; P = 0.06). These associations were unrelated to ethnicity, the presence of APOE-epsilon4 or dementia. Analyses by quartiles of homocysteine showed that these association were driven primarily by the fourth quartile. CONCLUSIONS: Plasma homocysteine is directly related to Abeta40. The association with Abeta42 is not significant. These results seem to indicate that homocysteine is related to aging but not specifically to AD.
Authors: A McCaddon; P Hudson; G Davies; A Hughes; J H Williams; C Wilkinson Journal: Dement Geriatr Cogn Disord Date: 2001 Sep-Oct Impact factor: 2.959
Authors: Richard A Frank; Douglas Galasko; Harald Hampel; John Hardy; Mony J de Leon; Pankaj D Mehta; Joseph Rogers; Eric Siemers; John Q Trojanowski Journal: Neurobiol Aging Date: 2003 Jul-Aug Impact factor: 4.673
Authors: Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler Journal: N Engl J Med Date: 2003-03-27 Impact factor: 91.245
Authors: Perminder S Sachdev; Michael J Valenzuela; Henry Brodaty; Xing Li Wang; Jeffrey Looi; Lisa Lorentz; Lesley Howard; Megan Jones; Alessandro S Zagami; David Gillies; David E L Wilcken Journal: Dement Geriatr Cogn Disord Date: 2003 Impact factor: 2.959
Authors: James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer Journal: JAMA Date: 2004-02-04 Impact factor: 56.272
Authors: Javier Pacheco-Quinto; Elena B Rodriguez de Turco; Steven DeRosa; Altovise Howard; Felix Cruz-Sanchez; Kumar Sambamurti; Lorenzo Refolo; Suzana Petanceska; Miguel A Pappolla Journal: Neurobiol Dis Date: 2006-03-03 Impact factor: 5.996
Authors: Fei Song; Anne Poljak; Michael Valenzuela; Richard Mayeux; George A Smythe; Perminder S Sachdev Journal: J Alzheimers Dis Date: 2011 Impact factor: 4.472
Authors: C Hooper; P De Souto Barreto; N Coley; E Caussé; P Payoux; A S Salabert; M Cesari; S Andrieu; G-L Bowman; M Weiner; B Vellas Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Nicholas M Pajewski; Fanny M Elahi; Manjula Kurella Tamura; Jason D Hinman; Ilya M Nasrallah; Joachim H Ix; Lindsay M Miller; Lenore J Launer; Clinton B Wright; Mark A Supiano; Alan J Lerner; Tiffany L Sudduth; Anthony A Killeen; Alfred K Cheung; David M Reboussin; Donna M Wilcock; Jeff D Williamson Journal: Alzheimers Dement Date: 2021-11-17 Impact factor: 16.655
Authors: Paul S Aisen; Lon S Schneider; Mary Sano; Ramon Diaz-Arrastia; Christopher H van Dyck; Myron F Weiner; Teodoro Bottiglieri; Shelia Jin; Karen T Stokes; Ronald G Thomas; Leon J Thal Journal: JAMA Date: 2008-10-15 Impact factor: 56.272
Authors: Babak Hooshmand; Tuomo Polvikoski; Miia Kivipelto; Maarit Tanskanen; Liisa Myllykangas; Timo Erkinjuntti; Mira Mäkelä; Minna Oinas; Anders Paetau; Philip Scheltens; Elizabeth C W van Straaten; Raimo Sulkava; Alina Solomon Journal: Brain Date: 2013-09 Impact factor: 13.501